(Credit: © Kurhan - stock.adobe.com)
In a Nutshell
- An oral compound called TOFA caused significant weight and fat loss in obese mice without reducing food intake or causing muscle loss, setting it apart from current obesity drugs.
- TOFA worked by boosting how much energy cells burn, rather than suppressing appetite, and it also improved blood sugar, harmful blood fats, and fatty liver disease.
- When combined with semaglutide or tirzepatide, TOFA outperformed
No comments:
Post a Comment